TCL Archive NCAB Disproves W. Virginia Construction Grant, Okays Funding Three New, Three Carryover Awards May 24, 1985
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive In Brief: Upton Okays Laetrile Clinical Trials, To Seek Protocols From Clinicians For IND Request October 6, 1978
